Research is ongoing to expand the use of Olaparib to other types of cancer and to combine it with other therapies for enhanced efficacy. Clinical trials are exploring its potential in treating a broader spectrum of cancers, as well as in combination with immunotherapies and other targeted treatments. The future looks promising for Olaparib as a cornerstone in the evolving landscape of personalized cancer treatment.